| 000 | 01317cam a2200313Ii 4500 | ||
|---|---|---|---|
| 001 | 9780429091858 | ||
| 008 | 180331t20162016fluad ob 001 0 eng d | ||
| 020 |
_a9780429091858 _q(e-book : PDF) |
||
| 020 |
_z9789814613767 _q(hardback) |
||
| 024 | 7 |
_a10.1201/b18615 _2doi |
|
| 035 | _a(OCoLC)915721816 | ||
| 040 |
_aFlBoTFG _cFlBoTFG _erda |
||
| 050 | 4 |
_aR857.N34 _bH44 |
|
| 082 | 0 | 4 |
_a610.28 _bH464 |
| 100 | 1 |
_aHehenberger, Michael, _eauthor. _911270 |
|
| 245 | 1 | 0 |
_aNanomedicine : _bscience, business, and impact / _cMichael Hehenberger. |
| 264 | 1 |
_aBoca Raton : _bCRC Press, _c[2016] |
|
| 264 | 4 | _c©2016 | |
| 300 | _a1 online resource | ||
| 336 |
_atext _2rdacontent |
||
| 337 |
_acomputer _2rdamedia |
||
| 338 |
_aonline resource _2rdacarrier |
||
| 504 | _aIncludes bibliographical references (pages 375-396) and index. | ||
| 505 | 0 | _a1. Introduction -- 2. From atoms to proteins -- 3. Genetics and DNA sequencing -- 4. Biopharmaceutical R&D -- 5. Nanomedicine -- 6. Impact of nanomedicine -- 7. The healthcare ecosystem and biomedical research funding -- 8. Public health and global health economics -- 9. Conclusions. | |
| 650 | 0 |
_aNanomedicine. _95252 |
|
| 776 | 0 | 8 |
_iPrint version: _z9789814613767 |
| 856 | 4 | 0 |
_uhttps://www.taylorfrancis.com/books/9789814613774 _zClick here to view. |
| 942 | _cEBK | ||
| 999 |
_c69925 _d69925 |
||